Delictase® sources lactase exogenously, attacking the cause of colic and contributing to better infant nutrition. Other medicines simply treat the symptoms of colic and don’t help babies get the monosaccharaides they need for development.
Boca Raton, Fla. (PRWEB) December 18, 2017
Neosanté Health Solutions is bringing its top-selling Delictase® Oral Drops, a lactase enzyme supplement used to battle baby colic, into the U.S. marketplace.
Neosanté Health Solutions is a privately owned Portuguese pharmaceutical company established in 2007 that produces food supplements, medical devices and cosmetics. Neosanté currently distributes products to 20 countries on three continents, and is bringing its most popular item, Delictase® Oral Drops, to the U.S.
Colic affects up to 40 percent of children, typically occurring when a child is between six weeks and six months old. The cause of baby colic, however, is not well understood. The symptom of colic involves excess crying in an otherwise healthy child, and it is believed that gastrointestinal discomfort, including intestinal cramping, is an underlying factor.
Lactase is essential for complete digestion of lactose, found in breast milk and baby formula. Delictase® provides lactase to infants, who may have a lactase deficiency known as hypolactasia. Delictase® Oral Drops come in a 15 milliliter solution, prepackaged in a dropper. It is designed for infants to have with their breast milk or baby formula.
“Delictase® is mainly for babies with infant colic,” Neosanté CEO João Santos said. “Many babies have issues similar to lactose intolerance, causing severe digestive issues. Delictase® breaks lactose down into glucose and galactose that babies need.”
Fermentation of undigested lactose in the baby’s intestine can lead to gas, pain and bloating. Undigested lactose also makes the colon more acidic, leading to loose stool and diarrhea. Babies might develop lactase in time, or be lactose intolerant until adulthood. Colic rarely lasts more than a year and is not a sign of permanent ailment or disease.
“Delictase® sources lactase exogenously, attacking the cause of colic and contributing to better infant nutrition,” Santos said. “Other medicines simply treat the symptoms of colic and don’t help babies get the monosaccharaides they need for development.”
Neosanté sold more than two million vials of Delictase® Oral Drops in 2017 alone, predominately to health-conscious parents coping with baby colic. The company also sells Delictase® Capsules, which come in a pack of 30, and are aimed at lactose intolerant children and adults.